Description
Two securities moved to higher GSM stages - Shashank Traders to Stage II and Adline Chem Lab to Stage III under enhanced surveillance.
Summary
BSE has moved two securities to higher stages under the Graded Surveillance Measure (GSM) framework. Shashank Traders Ltd has been moved to GSM Stage II, while Adline Chem Lab Ltd has been moved to GSM Stage III, indicating increased surveillance and stricter trading conditions.
Key Points
- Shashank Traders Ltd (Security Code: 540221, ISIN: INE508R01018) moved to GSM Stage II
- Adline Chem Lab Ltd (Security Code: 524604, ISIN: INE276T01018) moved to GSM Stage III
- Higher GSM stages impose stricter trading conditions and enhanced monitoring
- Framework includes provisions for securities moving to lower stages due to ESM or IBC inclusion
Regulatory Changes
The securities have been reclassified under BSE’s Graded Surveillance Measure framework, which applies progressive restrictions based on price volatility, trading volumes, and other risk parameters.
Compliance Requirements
- Trading members must comply with enhanced surveillance conditions for these securities
- Investors should be aware of potential trading restrictions and margin requirements
- Securities under higher GSM stages may have specific position limits and delivery obligations
Important Dates
- Circular Date: August 21, 2025
- Stage changes are typically effective from the next trading session
Impact Assessment
The move to higher GSM stages will result in increased margin requirements, potential reduction in trading volumes, and enhanced scrutiny of price movements for both securities. Investors should exercise caution when trading these stocks due to the enhanced surveillance measures.
Impact Justification
Surveillance stage changes affect trading parameters and investor attention for specific securities